[ Price : $8.95]
FDA suggests that Repros Therapeutics conduct a Phase 2B Androxal trial before moving to Phase 3 studies.[ Price : $8.95]
FDA grants Sanofi Pasteur a fast track designation for its investigational clostridium difficile vaccine candidate.[ Price : $8.95]
FDA says it has developed recommendations that should reduces instances of excess doses of radiation to some patients undergoing C...[ Price : $8.95]
CDERs Division of Drug Marketing, Advertising, and Communications warns Tercica about misleading professional promotional material...[ Price : $8.95]
FDA warns Claris Lifesciences on multiple violations found at its Indian and U.S. facilities.[ Price : $8.95]
A federal grand jury indicts former Glaxo attorney Lauren Stevens for lying to FDA about off-label promotion of a drug.[ Price : $8.95]
Federal Register Notice: FDA makes available the status of postmarketing requirements for approved drug and biological products.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Bioenergy, Claris Lifesciences, CP Pharmaceuticals, and Ipsen Group-Tercica.